The remodeling of tumor blood vessels and anti-angiogenic effects of anti-CTLA-4 antibodies require the presence of CD4+ T cells and the activity of IFNγ, a potent anti-angiogenic cytokine.47 The gene discussed is CD4; the disease is neoplasm.